(Q22241488)

PubMed

PubMed publication ID

7 February 2023

James S Rothel

1

James S

Rothel

1 reference

PubMed

PubMed publication ID

16307510

Expert Review of Anti-infective Therapy

7 February 2023

language of work or name

English

0 references

publication date

December 2005

0 references

published in

0 references

volume

3

0 references

issue

6

0 references

page(s)

981-993

0 references

cites work

Tuberculosis and HIV/AIDS: epidemiological and clinical aspects (world perspective).

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

21 January 2018

The tuberculin skin test

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Comparable specificity of 2 commercial tuberculin reagents in persons at low risk for tuberculous infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Underreading of the tuberculin skin test reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

How can immunology contribute to the control of tuberculosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Review: the immune response in human tuberculosis--implications for tuberculosis control

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Clinical correlates of interferon gamma production in patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: relationship with the severity of pulmonary involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Specific immune-based diagnosis of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Identification and characterization of the ESAT-6 homologue of Mycobacterium leprae and T-cell cross-reactivity with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Comparative genomics of BCG vaccines by whole-genome DNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Antigenic equivalence of human T-cell responses to Mycobacterium tuberculosis-specific RD1-encoded protein antigens ESAT-6 and culture filtrate protein 10 and to mixtures of synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

ESAT-6/CFP-10 fusion protein and peptides for optimal diagnosis of mycobacterium tuberculosis infection by ex vivo enzyme-linked immunospot assay in the Gambia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

A sandwich enzyme immunoassay for bovine interferon-gamma and its use for the detection of tuberculosis in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Association of tuberculin-boosted antibody responses with pathology and cell-mediated immunity in cattle vaccinated with Mycobacterium bovis BCG and infected with M. bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Diagnosis of tuberculosis in South African children with a T-cell-based assay: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Costs of implementing and maintaining a tuberculin skin test program in hospitals and health departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Early diagnosis of subclinical multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Human Th1 Cell Lines Recognize the Mycobacterium tuberculosis ESAT-6 Antigen and its Peptides in Association with Frequently Expressed HLA Class II Molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

Mycobacterium tuberculosis Infection in Health Care Workers in Rural India

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Discrepancy between the tuberculin skin test and the whole-blood interferon gamma assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Development of a simple, rapid in vitro cellular assay for bovine tuberculosis based on the production of gamma interferon

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Building a better tuberculosis vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Cytokine production in children with tuberculous infection and disease

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Use of synthetic peptides derived from the antigens ESAT-6 and CFP-10 for differential diagnosis of bovine tuberculosis in cattle

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Tuberculin skin testing compared with T-cell responses to Mycobacterium tuberculosis-specific and nonspecific antigens for detection of latent infection in persons with recent tuberculosis contact

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021

Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment

1 reference

https://api.crossref.org/works/10.1586%2F14787210.3.6.981

7 January 2021